Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review

Amy C. Plint; David Moher; Andra Morrison; Kenneth F. Schulz; Douglas G. Altman; Catherine Hill; Isabelle Gaboury

doi:10.5694/j.1326-5377.2006.tb00557.x

Related publications

Article2011

The influence of CONSORT on the quality of reporting of randomised controlled trials: an updated review

Lucy Turner, David Moher, Larissa Shamseer, Laura Weeks, Jodi Peters, Amy C. Plint, Douglas G. Altman, Kenneth F. Schulz

Article2024

Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines

Alexander P. L. Martindale, Carrie Llewellyn, Richard de Visser, Benjamin Ng, Victoria Ngai, Aditya U. Kale, Lavinia Ferrante di Ruffano, Robert Golub, Gary S. Collins, David Moher, Melissa D. McCradden, Lauren Oakden‐Rayner, Samantha Cruz Rivera, Melanie Calvert, Christopher Kelly, Cecilia S. Lee, Christopher Yau, An‐Wen Chan, Pearse A. Keane, Andrew L. Beam, Alastair K. Denniston, Xiaoxuan Liu

Article2012

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa

Lucy Turner, Larissa Shamseer, Douglas G. Altman, Kenneth F. Schulz, David Moher

Article2012

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals

Lucy Turner, Larissa Shamseer, Douglas G. Altman, Laura Weeks, Jodi Peters, Thilo Kober, Sofia Dias, Kenneth F. Schulz, Amy C. Plint, David Moher

Article2020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Douglas G. Altman, Kenneth F. Schulz, David Moher